Advertisement

Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions

Published:February 10, 2015DOI:https://doi.org/10.1016/j.hrthm.2015.02.010

      Background

      Permanent cardiac pacemakers have historically been considered a contraindication to magnetic resonance imaging (MRI).

      Objective

      The purpose of the ProMRI/ProMRI AFFIRM Study, which was a multicenter, prospective, single-arm, nonrandomized study, was to evaluate the clinical safety of the Biotronik ProMRI Pacemaker System under specific MRI conditions.

      Methods

      The ProMRI Study (in the United States) and the ProMRI AFFIRM study (outside the United States) with identical design enrolled 272 patients with stable baseline pacing indices implanted with an Entovis or Evia pacemaker (DR-T or SR-T) and Setrox or Safio 53-cm or 60-cm lead. Device interrogation was performed at enrollment, pre-MRI and post-MRI scan, and 1 and 3 months post-MRI. End-points were (1) freedom from MRI- and pacing system–related serious adverse device effects (SADEs) through 1 month post-MRI, (2) freedom from atrial and ventricular MRI-induced pacing threshold increase (>0.5 V), and (3) freedom from P- and R-wave amplitude attenuation (<50%), or P wave <1.5 mV, or R wave <5.0 mV at 1 month post-MRI.

      Results

      Two hundred twenty-six patients completed the MRI and 1-month post-MRI follow-up. No adverse events related to the implanted system and the MRI procedure occurred, resulting in an SADE-free rate of 100.0% (229/229, P <.001). Freedom from atrial and ventricular pacing threshold increase was 99.0% (189/191, P = .003) and 100% (217/217, P <.001), respectively. Freedom from P- and R- wave amplitude attenuation was 99.4% (167/168, P <.001) and 99.5% (193/194, P <.001), respectively.

      Conclusion

      The results of the ProMRI/ProMRI AFFIRM studies demonstrate the clinical safety and efficacy of the ProMRI pacemaker system in patients subjected to head and lower lumbar MRI conditions.

      Abbreviations:

      CI (confidence interval), MR (magnetic resonance), MRI (magnetic resonance imaging), SADE (serious adverse device effect), SAR (specific absorption rate)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kalin R.
        • Stanton M.S.
        Current clinical issues for MRI scanning of pacemaker and defibrillator patients.
        Pacing Clin Electrophysiol. 2005; 28: 326-328
        • Luechinger R.
        • Duru F.
        Do we need MR conditional pacemakers?.
        Kardiovaskuläre Medizin. 2010; 13: 70-74
        • Erlebacher J.A.
        • Cahill P.T.
        • Pannizzo F.
        • Knowles R.J.
        Effect of magnetic resonance imaging on DDD pacemakers.
        Am J Cardiol. 1986; 57: 437-440
        • Fetter J.
        • Aram G.
        • Holmes Jr, D.R.
        • Gray J.E.
        • Hayes D.L.
        The effects of nuclear magnetic resonance imagers on external and implantable pulse generators.
        Pacing Clin Electrophysiol. 1984; 7: 720-727
        • Pavlicek W.
        • Geisinger M.
        • Castle L.
        • Borkowski G.P.
        • Meaney T.F.
        • Bream B.L.
        • Gallagher J.H.
        The effects of nuclear magnetic resonance on patients with cardiac pacemakers.
        Radiology. 1983; 147: 149-153
        • Sommer T.
        • Vahlhaus C.
        • Lauck G.
        • von Smekal A.
        • Reinke M.
        • Hofer U.
        • Block W.
        • Träber F.
        • Schneider C.
        • Gieseke J.
        • Jung W.
        • Schild H.
        MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T.
        Radiology. 2000; 215: 869-879
        • Coman J.A.
        • Martin E.T.
        • Ramza B.M.
        • Margolis P.D.
        • Fair R.D.
        Pacemaker safety during magnetic resonance imaging at 1.5 Tesla (abstract).
        J Am Coll Cardiol. 2001; 37: 436A
        • Levine G.N.
        • Gomes A.S.
        • Arai A.E.
        • et al.
        Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance.
        Circulation. 2007; 116: 2878-2891
        • Vardas P.E.
        • Auricchio A.
        • Blanc J.J.
        • et al.
        Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.
        Europace. 2007; 9: 959-998
        • Wilkoff B.L.
        • Bello D.
        • Taborsky M.
        • et al.
        Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment.
        Heart Rhythm. 2011; 8: 65-73
        • Gimbel J.R.
        • Bello D.
        • Schmitt M.
        • Merkely B.
        • Schwitter J.
        • Hayes D.L.
        • Sommer T.
        • Schloss E.J.
        • Chang Y.
        • Willey S.
        • Kanal E.
        • Advisa M.R.I.
        System Study Investigators. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla.
        Heart Rhythm. 2013; 10: 685-691
        • Schwitter J.
        • Kanal E.
        • Schmitt M.
        • Anselme F.
        • Albert T.
        • Hayes D.L.
        • Bello D.
        • Tóth A.
        • Chang Y.
        • van Osch D.
        • Sommer T.
        • Advisa M.R.I.
        System Study Investigators: impact of the Advisa MRI pacing system on the diagnostic quality of cardiac MR images and contraction patterns of cardiac muscle during scans: Advisa MRI randomized clinical multicenter study results.
        Heart Rhythm. 2013; 10: 864-872
        • Tracy C.M.
        • Epstein A.E.
        • Darbar D.
        • et al.
        2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2013; 61: e6-e75
      1. Biotronik Cardiac Rhythm Management Product Performance Report, January 2014. Accessed June 4, 2014. Available at: http://www.biotronik.com/files/E3C148A8C88E9E4EC1257AEE004C5CF0/$FILE/product_performance_report_EN.pdf.

        • Rickard J.
        • Taborsky M.
        • Bello D.
        • Johnson W.B.
        • Ramza B.
        • Yanping C.
        • Wilkoff B.
        Short- and long-term electrical performance of the 5086MRI pacing lead.
        Heart Rhythm. 2014; 11: 222-229
        • Nazarian S.
        • Roguin A.
        • Zviman M.M.
        • Lardo A.C.
        • Dickfeld T.L.
        • Calkins H.
        • Weiss R.G.
        • Berger R.D.
        • Bluemke D.A.
        • Halperin H.R.
        Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.
        Circulation. 2006; 114: 1277-1284
        • Mollerus M.
        • Albin G.
        • Lipinski M.
        • Lucca J.
        Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions.
        Europace. 2010; 12: 947-951
        • Gimbel J.R.
        The safety of MRI scanning of pacemakers and ICDs: what are the critical elements of safe scanning? Ask me again at 10,000.
        Europace. 2010; 12: 915-917
        • Mond H.G.
        • Irwin M.
        • Ector H.
        • Proclemer A.
        The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project.
        Pacing Clin Electrophysiol. 2008; 31: 1202-1212
        • Wilkoff B.L.
        • Albert T.
        • Lazebnik M.
        • Park S.M.
        • Edmonson J.
        • Herberg B.
        • Golnitz J.
        • Wixon S.
        • Peltier J.
        • Yoon H.
        • Willey S.
        • Safriel Y.
        Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modeling.
        Heart Rhythm. 2013; 10: 1815-1821